WallStreetZenWallStreetZen

NASDAQ: SCPH
Scpharmaceuticals Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for SCPH

Based on 2 analysts offering 12 month price targets for Scpharmaceuticals Inc

Min Forecast
$12.00+117.39%
Avg Forecast
$15.00+171.74%
Max Forecast
$18.00+226.09%

Should I buy or sell SCPH stock?

Based on 2 analysts offering ratings for Scpharmaceuticals Inc.

Strong Buy
Strong Buy
1 analysts 50%
Buy
1 analysts 50%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although SCPH's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates SCPH as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their SCPH stock forecasts and price targets.

SCPH stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-03-20
lockedlocked$00.00+00.00%2025-03-20

1 of 1

Forecast return on equity

Is SCPH forecast to generate an efficient return?

Company
-1,112.06%
Industry
123.58%
Market
-47.74%
SCPH's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is SCPH forecast to generate an efficient return on assets?

Company
62.68%
Industry
46.72%
SCPH is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

SCPH earnings per share forecast

What is SCPH's earnings per share in the next 3 years based on estimates from 3 analysts?

Avg 1 year Forecast
-$1.11
Avg 2 year Forecast
-$0.16
Avg 3 year Forecast
$0.26

SCPH revenue forecast

What is SCPH's revenue in the next 3 years based on estimates from 2 analysts?

Avg 1 year Forecast
$75.5M+79.84%
Avg 2 year Forecast
$140.4M+234.42%
Avg 3 year Forecast
$195.3M+365.26%
SCPH's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

SCPH revenue growth forecast

How is SCPH forecast to perform vs Biotechnology companies and vs the US market?

Company
67.41%
Industry
80.59%
Market
10.89%
SCPH's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
SCPH's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

SCPH vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
SCPH$5.52$15.00+171.74%Strong Buy
CTNM$10.39$22.75+118.96%Strong Buy
RNAC$11.25$39.33+249.63%Buy
OMER$4.35$22.50+417.24%Strong Buy
DSGN$5.20N/AN/A
View Top Biotech Stocks

Scpharmaceuticals Stock Forecast FAQ

Is Scpharmaceuticals Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: SCPH) stock is to Strong Buy SCPH stock.

Out of 2 analysts, 1 (50%) are recommending SCPH as a Strong Buy, 1 (50%) are recommending SCPH as a Buy, 0 (0%) are recommending SCPH as a Hold, 0 (0%) are recommending SCPH as a Sell, and 0 (0%) are recommending SCPH as a Strong Sell.

If you're new to stock investing, here's how to buy Scpharmaceuticals stock.

What is SCPH's earnings growth forecast for 2025-2027?

(NASDAQ: SCPH) Scpharmaceuticals's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 5.36%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 15.32%.

Scpharmaceuticals's earnings in 2025 is -$90,782,000.On average, 3 Wall Street analysts forecast SCPH's earnings for 2025 to be -$58,424,882, with the lowest SCPH earnings forecast at -$61,238,694, and the highest SCPH earnings forecast at -$55,431,577. On average, 3 Wall Street analysts forecast SCPH's earnings for 2026 to be -$8,620,930, with the lowest SCPH earnings forecast at -$23,756,390, and the highest SCPH earnings forecast at $10,558,396.

In 2027, SCPH is forecast to generate $13,725,914 in earnings, with the lowest earnings forecast at $12,670,075 and the highest earnings forecast at $14,781,754.

What is SCPH's revenue growth forecast for 2025-2027?

(NASDAQ: SCPH) Scpharmaceuticals's forecast annual revenue growth rate of 67.41% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 80.59%, and while it is forecast to beat the US market's average forecast revenue growth rate of 10.89%.

Scpharmaceuticals's revenue in 2025 is $41,982,000.On average, 2 Wall Street analysts forecast SCPH's revenue for 2025 to be $3,985,794,339, with the lowest SCPH revenue forecast at $3,748,230,438, and the highest SCPH revenue forecast at $4,223,358,240. On average, 2 Wall Street analysts forecast SCPH's revenue for 2026 to be $7,411,729,751, with the lowest SCPH revenue forecast at $6,408,418,209, and the highest SCPH revenue forecast at $8,415,041,293.

In 2027, SCPH is forecast to generate $10,311,593,103 in revenue, with the lowest revenue forecast at $8,956,159,068 and the highest revenue forecast at $11,667,027,138.

What is SCPH's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: SCPH) forecast ROA is 62.68%, which is higher than the forecast US Biotechnology industry average of 46.72%.

What is SCPH's Price Target?

According to 2 Wall Street analysts that have issued a 1 year SCPH price target, the average SCPH price target is $15.00, with the highest SCPH stock price forecast at $18.00 and the lowest SCPH stock price forecast at $12.00.

On average, Wall Street analysts predict that Scpharmaceuticals's share price could reach $15.00 by Mar 20, 2026. The average Scpharmaceuticals stock price prediction forecasts a potential upside of 171.74% from the current SCPH share price of $5.52.

What is SCPH's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: SCPH) Scpharmaceuticals's current Earnings Per Share (EPS) is -$1.87. On average, analysts forecast that SCPH's EPS will be -$1.11 for 2025, with the lowest EPS forecast at -$1.16, and the highest EPS forecast at -$1.05. On average, analysts forecast that SCPH's EPS will be -$0.16 for 2026, with the lowest EPS forecast at -$0.45, and the highest EPS forecast at $0.20. In 2027, SCPH's EPS is forecast to hit $0.26 (min: $0.24, max: $0.28).

What is SCPH's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: SCPH) forecast ROE is -1,112.06%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.